ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
10.25
-0.19 (-1.82%)
Oct 23, 2026, 4:00 PM EDT - Market closed

ImmuCell Revenue

ImmuCell had revenue of $7.19M in the quarter ending June 30, 2026, with 11.50% growth. This brings the company's total for the last twelve months to $30.68M, up 8.49% year-over-year. In the year 2025, ImmuCell had annual revenue of $27.64M with 4.34% growth. That makes ImmuCell the 31,225th largest company in the world by revenue and 4,128th in the United States.

Revenue (ttm)
$30.68M
Revenue Growth
+8.49%
P/S Ratio
3.03
Revenue / Employee
$420,213
Employees
73
Market Cap
93.09M

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Scours 27.45M 99.3%
  • Mastitis 196.39K 0.7%

By Geography

Chart
  • United States 24.39M 88.2%
  • Other 3.25M 11.8%
Fiscal year ended Dec 31, 2025 See the full ImmuCell breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202527.64M1.15M4.34%
Dec 31, 202426.49M9.02M51.64%
Dec 31, 202317.47M-1.10M-5.90%
Dec 31, 202218.57M-675.01K-3.51%
Dec 31, 202119.24M3.90M25.43%
Dec 31, 202015.34M1.62M11.80%
Dec 31, 201913.72M2.74M24.91%
Dec 31, 201810.99M555.21K5.32%
Dec 31, 201710.43M887.13K9.30%
Dec 31, 20169.54M-684.73K-6.69%
Dec 31, 201510.23M2.63M34.64%
Dec 31, 20147.60M1.59M26.46%
Dec 31, 20136.01M617.24K11.45%
Dec 31, 20125.39M278.79K5.45%
Dec 31, 20115.11M724.95K16.53%
Dec 31, 20104.39M-119.56K-2.65%
Dec 31, 20094.51M-122.55K-2.65%
Dec 31, 20084.63M-6.21M-57.31%
Dec 31, 200710.84M1.73M19.04%
Dec 31, 20069.11M-109.26K-1.19%
Dec 31, 20059.22M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.